Showing results (191-200 of 200) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 200 results.
Clinical Nuclear Medicine|September 1, 1990
I-123 hydroxyiodobenzyl propanediamine (HIPDM) cerebral blood flow imaging demonstrating transtentorial diaschisisW J Shih, S T Dekosky, J J Coupal, et al.
Evaluation & the Health Professions|April 2, 2010
A longitudinal study of the impact of interviews on medical school admissions in TaiwanA P Fan, T C Tsai, T P Su, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 27, 2000
Single SPECT measures of cerebral cortical perfusion reflect time-index estimation of dementia severity in Alzheimer's diseaseJ W Ashford, W J Shih, J Coupal, et al.
Clinical Nuclear Medicine|March 1, 1993
Lung uptake of Tc-99m HMPAO in cigarette smokers expressed by lung/liver activity ratioW J Shih, S R Rehm, F Grunwald, et al.
Statistics in Medicine|March 1, 1993
Monitoring of clinical trials and interim analyses from a drug sponsor's point of viewG W Williams, R L Davis, A J Getson, et al.
Oncology Research|November 8, 2001
Synergistic effects of clinically achievable concentrations of 12-O-tetradecanoylphorbol-13-acetate in combination with all-trans retinoic acid, 1alpha,25-dihydroxyvitamin D3, and sodium butyrate on differentiation in HL-60 cellsX Zheng, R L Chang, X X Cui, et al.
Cancer|October 12, 2001
Mitoxantrone in patients with prostate specific antigen progression after local therapy for prostate carcinomaR S DiPaola, E S Chenven, W J Shih, et al.
Cancer Research|December 15, 1990
Characterization of high specific activity [16 alpha-123I]Iodo-17 beta-estradiol as an estrogen receptor-specific radioligand capable of imaging estrogen receptor-positive tumorsE J Pavlik, K Nelson, H H Gallion, et al.
Circulation|August 23, 2000
Effect of cholesterol-lowering therapy on coronary endothelial vasomotor function in patients with coronary artery diseaseJ A Vita, A C Yeung, M Winniford, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|November 30, 2014
Odanacatib for the treatment of postmenopausal osteoporosis: development history and design and participant characteristics of LOFT, the Long-Term Odanacatib Fracture TrialH G Bone, D W Dempster, J A Eisman, et al.
Pageof 20